SEARCH

SEARCH BY CITATION

References

  • Adkins E. M., Samuvel D. J., Fog J. U., Eriksen J., Jayanthi L. D., Vaegter C. B., Ramamoorthy S. and Gether U. (2007) Membrane Mobility and Microdomain Association of the Dopamine Transporter Studied with Fluorescence Correlation Spectroscopy and Fluorescence Recovery after Photobleaching. Biochemistry 46, 1048410497.
  • Anderson R. G. (1998) The caveolae membrane system. Annu. Rev. Biochem. 67, 199225.
  • Anderson R. G. and Jacobson K. (2002) A role for lipid shells in targeting proteins to caveolae, rafts, and other lipid domains. Science 296, 18211825.
  • Bauman A. L., Apparsundaram S., Ramamoorthy S., Wadzinski B. E., Vaughan R. A. and Blakely R. D. (2000) Cocaine and antidepressant-sensitive biogenic amine transporters exist in regulated complexes with protein phosphatase 2A. J. Neurosci. 20, 75717578.
  • Bi K., Tanaka Y., Coudronniere N., Sugie K., Hong S., Van Stipdonk M. J. and Altman A. (2001) Antigen-induced translocation of PKC-theta to membrane rafts is required for T cell activation. Nat. Immunol. 2, 556563.
  • Brazer S. C., Singh B. B., Liu X., Swaim W. and Ambudkar I. S. (2003) Caveolin-1 contributes to assembly of store-operated Ca2+ influx channels by regulating plasma membrane localization of TRPC1. J. Biol. Chem. 278, 2720827215.
  • Brown D. A. and London E. (2000) Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J. Biol. Chem. 275, 1722117224.
  • Caroni P. (2001) New EMBO members’ review: actin cytoskeleton regulation through modulation of PI(4,5)P(2) rafts. EMBO J. 20, 43324336.
  • Carroll F. I., Gao Y., Abraham P., Lewin A. H., Lew R., Patel A., Boja J. W. and Kuhar M. J. (1992) Probes for the cocaine receptor. Potentially irreversible ligands for the dopamine transporter. J. Med. Chem. 35, 18131817.
  • Cervinski M. A., Foster J. D. and Vaughan R. A. (2005) Psychoactive substrates stimulate dopamine transporter phosphorylation and down-regulation by cocaine-sensitive and protein kinase C-dependent mechanisms. J. Biol. Chem. 280, 4044240449.
  • Chi L. and Reith M. E. (2003) Substrate-induced trafficking of the dopamine transporter in heterologously expressing cells and in rat striatal synaptosomal preparations. J. Pharmacol. Exp. Ther. 307, 729736.
  • Dalskov S. M., Immerdal L., Niels-Christiansen L. L., Hansen G. H., Schousboe A. and Danielsen E. M. (2005) Lipid raft localization of GABA A receptor and Na+, K+-ATPase in discrete microdomain clusters in rat cerebellar granule cells. Neurochem. Int. 46, 489499.
  • Daniels G. M. and Amara S. G. (1999) Regulated trafficking of the human dopamine transporter. Clathrin- mediated internalization and lysosomal degradation in response to phorbol esters. J. Biol. Chem. 274, 3579435801.
  • Edidin M. (2003) The state of lipid rafts: from model membranes to cells. Annu. Rev. Biophys. Biomol. Struct. 32, 257283.
  • Eshleman A. J., Henningsen R. A., Neve K. A. and Janowsky A. (1994) Release of dopamine via the human transporter. Mol. Pharmacol. 45, 312316.
  • Falkenburger B. H., Barstow K. L. and Mintz I. M. (2001) Dendrodendritic inhibition through reversal of dopamine transport. Science 293, 24652470.
  • Fischer J. F. and Cho A. K. (1979) Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model. J. Pharmacol. Exp. Ther. 208, 203209.
  • Fog J. U., Khoshbouei H., Holy M. et al. (2006) Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport. Neuron 51, 417429.
  • Foger N., Marhaba R. and Zoller M. (2001) Involvement of CD44 in cytoskeleton rearrangement and raft reorganization in T cells. J. Cell Sci. 114, 11691178.
  • Foster J. D., Pananusorn B. and Vaughan R. A. (2002) Dopamine transporters are phosphorylated on N-terminal serines in rat striatum. J. Biol. Chem. 277, 2517825186.
  • Foster J. D., Pananusorn B., Cervinski M. A., Holden H. E. and Vaughan R. A. (2003) Dopamine transporters are dephosphorylated in striatal homogenates and in vitro by protein phosphatase 1. Brain Res. Mol. Brain Res. 110, 100108.
  • Foster J. D., Adkins S. A. and Vaughan R. A. (2006) Membrane raft association and trafficking-independent regulation of the dopamine transporter. Program No. 39.13, Abstract Viewer/Itinerary Planner. Society for Neuroscience, Washington, DC, Online.
  • Gaffaney J. D. and Vaughan R. A. (2004) Uptake inhibitors but not substrates induce protease resistance in extracellular loop two of the dopamine transporter. Mol. Pharmacol. 65, 692701.
  • Giros B., Jaber M., Jones S. R., Wightman R. M. and Caron M. G. (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606612.
  • Golub T., Wacha S. and Caroni P. (2004) Spatial and temporal control of signaling through lipid rafts. Curr. Opin. Neurobiol. 14, 542550.
  • Gorentla B. K. and Vaughan R. A. (2005) Differential effects of dopamine and psychoactive drugs on dopamine transporter phosphorylation and regulation. Neuropharmacology 49, 759768.
  • Gorentla B. K. and Vaughan R. A. (2006) Multiple protein kinases phosphorylate the N-terminal tail of DAT in vitro. Program No. 35.16, Abstract Viewer/Itinerary Planner. Society for Neuroscience, Washington, DC, Online.
  • Granas C., Ferrer J., Loland C. J., Javitch J. A. and Gether U. (2003) N-terminal truncation of the dopamine transporter abolishes phorbol ester- and substance P receptor-stimulated phosphorylation without impairing transporter internalization. J. Biol. Chem. 278, 49905000.
  • Gu H., Wall S. C. and Rudnick G. (1994) Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence. J. Biol. Chem. 269, 71247130.
  • Gu H. H., Ahn J., Caplan M. J., Blakely R. D., Levey A. I. and Rudnick G. (1996) Cell-specific sorting of biogenic amine transporters expressed in epithelial cells. J. Biol. Chem. 271, 1810018106.
  • Gulley J. M. and Zahniser N. R. (2003) Rapid regulation of dopamine transporter function by substrates, blockers and presynaptic receptor ligands. Eur. J. Pharmacol. 479, 139152.
  • Hering H., Lin C. C. and Sheng M. (2003) Lipid rafts in the maintenance of synapses, dendritic spines, and surface AMPA receptor stability. J. Neurosci. 23, 32623271.
  • Itoh K., Sakakibara M., Yamasaki S., Takeuchi A., Arase H., Miyazaki M., Nakajima N., Okada M. and Saito T. (2002) Cutting edge: negative regulation of immune synapse formation by anchoring lipid raft to cytoskeleton through Cbp-EBP50-ERM assembly. J. Immunol. 168, 541544.
  • Jayanthi L. D., Samuvel D. J. and Ramamoorthy S. (2004) Regulated internalization and phosphorylation of the native norepinephrine transporter in response to phorbol esters. Evidence for localization in lipid rafts and lipid raft-mediated internalization. J. Biol. Chem. 279, 1931519326.
  • Jayanthi L. D., Samuvel D. J., Blakely R. D. and Ramamoorthy S. (2005) Evidence for biphasic effects of protein kinase C on serotonin transporter function, endocytosis, and phosphorylation. Mol. Pharmacol. 67, 20772087.
  • Kahlig K. M., Javitch J. A. and Galli A. (2004) Amphetamine regulation of dopamine transport. Combined measurements of transporter currents and transporter imaging support the endocytosis of an active carrier. J. Biol. Chem. 279, 89668975.
  • Kantor L. and Gnegy M. E. (1998) Protein kinase C inhibitors block amphetamine-mediated dopamine release in rat striatal slices. J. Pharmacol. Exp. Ther. 284, 592598.
  • Khoshbouei H., Sen N., Guptaroy B., Johnson L., Lund D., Gnegy M. E., Galli A. and Javitch J. A. (2004) N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux. PLoS Biol. 2, E78.
  • Kimmich G. A., Randles J. and Wilson J. (1994) Na(+)-coupled alanine transport in LLC-PK1 cells. Am. J. Physiol. 267, C11191129.
  • Lever J. R., Carroll F. I., Patel A., Abraham P., Boja J. W., Lewin A. H. and Lew R. (1993) Radiosynthesis of a photoaffinity probe for the cocaine receptor of the dopamine transporter: 3-(p-chlorophenyl) tropan-2-carboxylic acid m-([1251]-iodo)-p-azidophenethyl ester ([1251]-RTI-82). J. Labelled Compds. Radiopharm. 33, 11311137.
  • Liang N. Y. and Rutledge C. O. (1982) Evidence for carrier-mediated efflux of dopamine from corpus striatum. Biochem. Pharmacol. 31, 24792484.
  • Loder M. K. and Melikian H. E. (2003) The dopamine transporter constitutively internalizes and recycles in a protein kinase C-regulated manner in stably transfected PC12 cell lines. J. Biol. Chem. 278, 2216822174.
  • Macdonald J. L. and Pike L. J. (2005) A simplified method for the preparation of detergent-free lipid rafts. J. Lipid Res. 46, 10611067.
  • Magnani F., Tate C. G., Wynne S., Williams C. and Haase J. (2004) Partitioning of the serotonin transporter into lipid microdomains modulates transport of serotonin. J. Biol. Chem. 279, 3877038778.
  • Mazei-Robison M. S. and Blakely R. D. (2005) Expression studies of naturally occurring human dopamine transporter variants identifies a novel state of transporter inactivation associated with Val382Ala. Neuropharmacology 49, 737749.
  • Melikian H. E. (2004) Neurotransmitter transporter trafficking: endocytosis, recycling, and regulation. Pharmacol. Ther. 104, 1727.
  • Melikian H. E. and Buckley K. M. (1999) Membrane trafficking regulates the activity of the human dopamine transporter. J. Neurosci. 19, 76997710.
  • Miller G. W., Gainetdinov R. R., Levey A. I. and Caron M. G. (1999) Dopamine transporters and neuronal injury. Trends Pharmacol. Sci. 20, 424429.
  • Monastyrskaya K., Hostettler A., Buergi S. and Draeger A. (2005) The NK1 receptor localizes to the plasma membrane microdomains, and its activation is dependent on lipid raft integrity. J. Biol. Chem. 280, 71357146.
  • Mortensen O. V. and Amara S. G. (2003) Dynamic regulation of the dopamine transporter. Eur. J. Pharmacol. 479, 159170.
  • Munro S. (2003) Lipid rafts: elusive or illusive? Cell 115, 377388.
  • Nichols B. (2003) Caveosomes and endocytosis of lipid rafts. J. Cell Sci. 116, 47074714.
  • Nirenberg M. J., Vaughan R. A., Uhl G. R., Kuhar M. J. and Pickel V. M. (1996) The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons. J. Neurosci. 16, 436447.
  • Parton R. G. and Richards A. A. (2003) Lipid rafts and caveolae as portals for endocytosis: new insights and common mechanisms. Traffic 4, 724738.
  • Pike L. J. (2003) Lipid rafts: bringing order to chaos. J. Lipid Res. 44, 655667.
  • Pike L. J. (2004) Lipid rafts: heterogeneity on the high seas. Biochem. J. 378, 281292.
  • Pike L. J. (2005) Growth factor receptors, lipid rafts and caveolae: an evolving story. Biochim. Biophys. Acta 1746, 260273.
  • Pike L. J. (2006) Rafts defined: a report on the Keystone Symposium on Lipid Rafts and Cell Function. J. Lipid Res. 47, 15971598.
  • Pristupa Z. B., McConkey F., Liu F., Man H. Y., Lee F. J., Wang Y. T. and Niznik H. B. (1998) Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter. Synapse 30, 7987.
  • Ravichandran R. and Divakar S. (1998) Inclusion of ring A of cholesterol inside the β-cyclodextrin cavity: evidence from oxidation reactions and structural studies. J Incl Phenom Mol Recognit Chem 30, 253270.
  • Roy S., Luetterforst R., Harding A., Apolloni A., Etheridge M., Stang E., Rolls B., Hancock J. F. and Parton R. G. (1999) Dominant-negative caveolin inhibits H-Ras function by disrupting cholesterol-rich plasma membrane domains. Nat. Cell Biol. 1, 98105.
  • Samuvel D. J., Jayanthi L. D., Bhat N. R. and Ramamoorthy S. (2005) A role for p38 mitogen-activated protein kinase in the regulation of the serotonin transporter: evidence for distinct cellular mechanisms involved in transporter surface expression. J. Neurosci. 25, 2941.
  • Saunders C., Ferrer J. V., Shi L., Chen J., Merrill G., Lamb M. E., Leeb-Lundberg L. M., Carvelli L., Javitch J. A. and Galli A. (2000) Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism. Proc. Natl Acad. Sci. USA 97, 68506855.
  • Scanlon S. M., Williams D. C. and Schloss P. (2001) Membrane cholesterol modulates serotonin transporter activity. Biochemistry 40, 1050710513.
  • Schnitzer J. E., Oh P., Pinney E. and Allard J. (1994) Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules. J. Cell Biol. 127, 12171232.
  • Shaikh S. R. and Edidin M. A. (2006) Membranes are not just rafts. Chem. Phys. Lipids 144, 13.
  • Shouffani A. and Kanner B. I. (1990) Cholesterol is required for the reconstruction of the sodium- and chloride-coupled, gamma-aminobutyric acid transporter from rat brain. J. Biol. Chem. 265, 60026008.
  • Song B. D., Leonard M. and Schmid S. L. (2004) Dynamin GTPase domain mutants that differentially affect GTP binding, GTP hydrolysis, and clathrin-mediated endocytosis. J. Biol. Chem. 279, 4043140436.
  • Sorkina T., Doolen S., Galperin E., Zahniser N. R. and Sorkin A. (2003) Oligomerization of dopamine transporters visualized in living cells by fluorescence resonance energy transfer microscopy. J. Biol. Chem. 278, 2827428283.
  • Sorkina T., Hoover B. R., Zahniser N. R. and Sorkin A. (2005) Constitutive and protein kinase C-induced internalization of the dopamine transporter is mediated by a clathrin-dependent mechanism. Traffic 6, 157170.
  • Sulzer D., Chen T. K., Lau Y. Y., Kristensen H., Rayport S. and Ewing A. (1995) Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J. Neurosci. 15, 41024108.
  • Sulzer D., Sonders M. S., Poulsen N. W. and Galli A. (2005) Mechanisms of neurotransmitter release by amphetamines: A review. Prog. Neurobiol. 75, 406433.
  • Varano F., Catarzi D., Colotta V., Calabri F. R., Lenzi O., Filacchioni G., Galli A., Costagli C., Deflorian F. and Moro S. (2005) 1-Substituted pyrazolo[1,5-c]quinazolines as novel Gly/NMDA receptor antagonists: synthesis, biological evaluation, and molecular modeling study. Bioorg. Med. Chem. 13, 55365549.
  • Vaughan R. A. (2000) Regulation of dopamine transporters by phosphorylation and impact on cocaine action, in Cerebral Signal Transduction: From First to Fourth Messengers (ReithM. E. A., ed.), pp. 375400. Humana Press Inc, Totowa, NJ.
  • Vaughan R. A. (2004) Phosphorylation and regulation of psychostimulant-sensitive neurotransmitter transporters. J. Pharmacol. Exp. Ther. 310, 17.
  • Vaughan R. A. and Kuhar M. J. (1996) Dopamine transporter ligand binding domains. Structural and functional properties revealed by limited proteolysis. J. Biol. Chem. 271, 2167221680.
  • Vaughan R. A., Huff R. A., Uhl G. R. and Kuhar M. J. (1997) Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes. J. Biol. Chem. 272, 1554115546.
  • Vaughan R. A., Parnas M. L., Gaffaney J. D., Lowe M. J., Wirtz S., Pham A., Reed B., Dutta S. M., Murray K. K. and Justice J. B. (2005) Affinity labeling the dopamine transporter ligand binding site. J. Neurosci. Methods 143, 3340.
  • Xing D., Chen P., Keil R. et al. (2000) Synthesis, biodistribution, and primate imaging of fluorine-18 labeled 2beta-carbo-1′-fluoro-2-propoxy-3beta-(4-chlorophenyl)tr opanes. Ligands for the imaging of dopamine transporters by positron emission tomography. J. Med. Chem. 43, 639648.
  • Zahniser N. R. and Doolen S. (2001) Chronic and acute regulation of Na+/Cl− -dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems. Pharmacol. Ther. 92, 2155.
  • Zahniser N. R. and Sorkin A. (2004) Rapid regulation of the dopamine transporter: role in stimulant addiction? Neuropharmacology 47(Suppl. 1), 8091.